Wire · opportunities
Noninvasive Focused Ultrasound Treatment Can Ease Motor Symptoms of Parkinson's Disease
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 October 2026 · Fusion42 review
A clinical trial demonstrated that bilateral magnetic resonance-guided focused ultrasound (MRgFUS) treatment can improve motor symptoms and tremors in Parkinson's disease patients by targeting the pallidothalamic tract. The FDA approved this staged bilateral noninvasive treatment in July 2025, and Medicare began covering it in March 2026.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You can now offer a noninvasive alternative to deep-brain stimulation for Parkinson's motor symptoms under Medicare coverage. This approval opens access to patients reluctant to undergo brain surgery and demands adapting your treatment and customer strategy accordingly.
◆ Coverage
1 source · 27 Oct 2026
◆ Related on Wire
◆ Topics